Information Provided By: 
Fly News Breaks for September 29, 2015
AGN
Sep 29, 2015 | 07:09 EDT
JPMorgan analyst Chris Schott says Allergan's second half of 2015 guidance last night fell largely in-line with expectations. The recent pullback in shares provides a "compelling" buying opportunity, the analyst tells investors in a research note. He keeps an Overweight rating on the stock with a $400 price target.
News For AGN From the Last 2 Days
There are no results for your query AGN
